Application of a Scavenger Receptor A1-Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV-Reference-Cited by-同舟云学术

Application of a Scavenger Receptor A1-Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV

Published:2020-08-25 Issue:10 Volume:17 Page:3794-3812
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Stevens David M.¹,Adiseshaiah Pavan¹,Dasa Siva S. K.¹,Potter Tim M.¹,Skoczen Sarah L.¹,Snapp Kelsie S.¹,Cedrone Edward¹,Patel Nimit²,Busman-Sahay Kathleen³,Rosen Elias P.⁴,Sykes Craig⁴,Cottrell Mackenzie⁴,Dobrovolskaia Marina A.¹,Estes Jacob D.³⁵,Kashuba Angela D. M.⁴,Stern Stephan T.¹

Affiliation:

1. Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States

2. Small Animal Imaging Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States

3. Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon 97006, United States

4. Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

5. Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon 97239, United States

Funder

National Cancer Institute

University of North Carolina at Chapel Hill

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00562

Reference59 articles.

1. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer